Monoclonal antibodies are novel therapeutic ... their efficacy and between the agents themselves. Antibodies against B cells Rituximab is a depleting antibody directed against CD20 on the surface ...
Monoclonal antibody design begins with identifying antibodies that bind to a specific target. One way to do this is to isolate antibody producing B-cells from human blood samples. Scientists then ...
ArkBio has concluded enrolment and dosing for a Phase I trial of AK0610, to prevent RSV infection, particularly in vulnerable ...
A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...
As cancer cells ... Chronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody ...
Fusion Antibodies PLC offers various antibody engineering services for all therapeutic ... Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal ...
First, using two different monoclonal antibodies that bind specifically to and inhibit either Notch1 or 2 (Lafkas et al., 2015), Abidi et al. showed that only inhibiting Notch1 reduced the ...